Navigation Links
China Medicine Announces Strong Second Quarter 2008 Results
Date:8/13/2008

ition to a patent granted in early 2004 from State Intellectual Property Office of China. The Company has applied for rADTZ patents in 13 different jurisdictions in 2007 (including Australia, Canada, the European Union, Indonesia, Israel, Japan, South Korea, Mexico, Russia, South Africa, the U.S., Hong Kong and India). China Medicine is currently testing rADTZ on animal feed and is scheduled to begin working with the Chinese Department of Agriculture on a large scale experiment in order to meet national standards and apply for production permits. Due to the 2008 Beijing Olympics Games, the application for a production permit will be delayed since the Chinese government mandated that all toxic tests and experiments be temporarily halted before and during the Olympics. Therefore, further testing on rADTZ will be suspended for approximately three months.

To date, the Company has been approached by potential customers for rADTZ, including a large scale chicken farm in Guangzhou Province; a leading international provider of food, agriculture and risk management products and services; and an international manufacturer of enzymes for the detergent, textile, and food and feed industries. "The entrance of rADTZ in the animal feed industry is relatively easy since we will only need approval from the Department of Agriculture in China, which is in contrast to entering the food industry, where the process might take years," said Mr. Yang. "Therefore, our target market is China's entire feed industry, which is approximately RMB 274.2 billion ($39.8 billion, 1 RMB = $0.145). In the next three years, we hope rADTZ will capture 20% of the animal feed market," said Mr. Yang.

"Based on our outstanding first half 2008 performance, we feel confident that we will meet our guidance of 25%-35% revenue growth and 30%-35% gross margins for fiscal 2008. In addition, based on our strong second quarter profitability, we expect to exceed our net income guidance of 20%-22% for 2008
'/>"/>

SOURCE China Medicine Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... PathoGenetix, Inc., a commercial-stage developer of an ... that it has successfully identified and strain typed a ... the Centers for Disease Control and Prevention (CDC) using ... are detailed in a poster presented at ... in Denver on Monday. , The 250 E. coli ...
(Date:5/20/2013)... Grace Century , an international ... science and health related private equity projects, has announced ... Project Team. Dergham's expertise in finance and international law ... Grace Century as it continues to look at more ... holds both an under graduate degree from the University ...
(Date:5/20/2013)... 20, 2013  (PSHR) Pacific Shore Holdings, Inc. ... across a broad range of product categories lines, ... relations firm, BlueWater Advisory Group, to provide strategic ... process, and to direct the company,s outreach and ... Matthew Mills , Pacific Shore ...
(Date:5/20/2013)... , Md. and BALTIMORE , May ... (BHI), a regional private-public partnership focusing on commercializing ... funding in Central Maryland , ... M.B.A., as the first Entrepreneur-in-Residence (EIR) for BHI ... National Heart, Lung and Blood Institute (NHLBI). ...
Breaking Biology Technology:New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 3Dalia Dergham Joins Grace Century FZ LLC International Project Team 2Pacific Shore Holdings Retains Investor Relations Firm 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 3BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 4
... FRANKFURT, Germany and LAUSANNE, Switzerland ... IMIDIA ("Innovative Medicines Initiative for,Diabetes"), a public private consortium ... launch of a project focusing on,pancreatic islet cell function ... to develop biomarkers and tools to pave the way,for ...
... CAMBRIDGE, England , June 14, 2010 Executives ... under,which O2h will provide Senexis with chemistry services to support a patent,filing ... disease modifying treatments for Alzheimer,s Disease. , ... Dr. Mark Treherne , CEO ...
... , NEW YORK and JERUSALEM , ... a privately held biopharma company, announced that it has ... safety and pharmacokinetics (PK) of its proprietary product Octreolin, ... administered orally. Octreolin demonstrated a PK profile similar ...
Cached Biology Technology:Launch of IMIDIA - An Innovative Medicines Initiative Project for Diabetes 2Launch of IMIDIA - An Innovative Medicines Initiative Project for Diabetes 3Launch of IMIDIA - An Innovative Medicines Initiative Project for Diabetes 4O2h Continues to Support Senexis to Support Patent Filing Senexis Limited 2Chiasma Reports Successful Oral Delivery Of A Peptide In Clinical Study 2Chiasma Reports Successful Oral Delivery Of A Peptide In Clinical Study 3Chiasma Reports Successful Oral Delivery Of A Peptide In Clinical Study 4Chiasma Reports Successful Oral Delivery Of A Peptide In Clinical Study 5Chiasma Reports Successful Oral Delivery Of A Peptide In Clinical Study 6Chiasma Reports Successful Oral Delivery Of A Peptide In Clinical Study 7Chiasma Reports Successful Oral Delivery Of A Peptide In Clinical Study 8Chiasma Reports Successful Oral Delivery Of A Peptide In Clinical Study 9
(Date:5/16/2013)... African-American adults living closer to a fast food restaurant ... who lived further away from fast food, according to ... Center, and this association was particularly strong among those ... published online in the American Journal of Public ... to a fast food restaurant, and among lower-income African-Americans, ...
(Date:5/16/2013)... a gene involved in neurodegenerative disease also plays a ... clock. , In a study of the common ... keeps the clock responsible for sleeping and waking on ... the fruit fly,s sleep-wake cycle is disturbed, making waking ... , The discovery is particularly interesting because mutations ...
(Date:5/16/2013)... the cellular layer lining the body,s blood vessels, ... nanometers in thickness, this super-tenuous structure routinely withstands ... to create a unique and highly dynamic barrier ... from the body,s circulatory system. , It,s also ... be physically breached to enable immune cells ...
Breaking Biology News(10 mins):Body mass index of low income African-Americans linked to proximity of fast food restaurants 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 3Gene involved in neurodegeneration keeps clock running 2Endothelium, heal thyself 2Endothelium, heal thyself 3Endothelium, heal thyself 4
... Alexandria, Va. The American Association for Dental Research ... AADR Neal W. Chilton Fellowship in Clinical Research recipient. ... & Exhibition in Washington, DC, March 3, 2010. ... associate director of the Delta Dental of Kentucky Clinical ...
... Foundation has awarded a $630,100 project support grant ... support the initial implementation this year of a ... for primary care providers, technical staff and health ... Building Blocks (HIBBs), a program developed by AMIA ...
... Lori Marino will speak on the anatomical basis of dolphin ... conference (AAAS) in San Diego, on Sunday, Feb. 21 at ... than our own and second in mass to the human ... leading expert in the neuroanatomy of dolphins and whales, Marino ...
Cached Biology News:Rockefeller Foundation supports expansion, training of e-health work force in developing world 2Rockefeller Foundation supports expansion, training of e-health work force in developing world 3
GOAT ANTI PPP2R5B...
acridine orange 10-nonyl bromide (nonyl acridine orange)...
Because it is manufactured at our ISO 9001–certified facilities in Eugene, Oregon, we can guarantee that FluoroPure grade propidium iodide is greater than or equal to 98% pure by HPLC....
MOUSE ANTI RAT RT1Bu Immunogen: Rat thymocyte membrane glycoproteins...
Biology Products: